Jennifer Brigitte Green, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3850, Durham, NC 27715
Phone (919) 668-8725
Email address green094@mc.duke.edu

Diabetes Mellitus: Prevention strategies, predictors, treatment effects, complications and cardiovascular outcomes. Utilization of EHR data to construct tools to improve the care of diabetes and comorbid conditions.

Education and Training

  • Resident, Internal Medicine, University of North Carolina at Chapel Hill School of Medicine, 1994 - 1996
  • Intern, Internal Medicine, University of North Carolina at Chapel Hill School of Medicine, 1993 - 1994
  • M.D., University of Virginia, 1993

Publications

Alfredsson, J, Green, JB, Stevens, SR, Reed, SD, Armstrong, PW, Angelyn Bethel, M, Engel, SS, McGuire, DK, Van de Werf, F, Hramiak, I, White, HD, Peterson, ED, Holman, RR, and TECOS Study Group, . "Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.(Accepted)" Diabetes, Obesity & Metabolism 20, no. 10 (October 2018): 2379-2388.

PMID
29923323
Full Text

Reed, SD, Li, Y, Leal, J, Radican, L, Adler, AI, Alfredsson, J, Buse, JB, Green, JB, Kaufman, KD, Riefflin, A, Van de Werf, F, Peterson, ED, Gray, AM, Holman, RR, and TECOS Study Group, . "Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes, Obesity & Metabolism 20, no. 7 (July 2018): 1732-1739.

PMID
29573215
Full Text

Green, JB, Hernandez, AF, D'Agostino, RB, Granger, CB, Janmohamed, S, Jones, NP, Leiter, LA, Noronha, D, Russell, R, Sigmon, K, Del Prato, S, and McMurray, JJV. "Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics." American Heart Journal 203 (June 12, 2018): 30-38.

PMID
30015066
Full Text

Wittbrodt, ET, Eudicone, JM, Bell, KF, Enhoffer, DM, Latham, K, and Green, JB. "Eligibility Varies Among the 4 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Outcomes Trials: Implications for the General Type 2 Diabetes US Population." American Journal of Managed Care 24, no. 8 (April 1, 2018): S138-S145. (Academic Article)

Scholars@Duke

Wittbrodt, ET, Eudicone, JM, Bell, KF, Enhoffer, DM, Latham, K, and Green, JB. "Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population." American Journal of Managed Care 24, no. 8 (April 1, 2018): S146-S155. (Academic Article)

Scholars@Duke

Standl, E, Stevens, SR, Armstrong, PW, Buse, JB, Chan, JCN, Green, JB, Lachin, JM, Scheen, A, Travert, F, Van de Werf, F, Peterson, ED, Holman, RR, and TECOS Study Group, . "Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype." Diabetes Care 41, no. 3 (March 2018): 596-603.

PMID
29311155
Full Text

Cefalu, WT, Kaul, S, Gerstein, HC, Holman, RR, Zinman, B, Skyler, JS, Green, JB, Buse, JB, Inzucchi, SE, Leiter, LA, Raz, I, Rosenstock, J, and Riddle, MC. "Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum." Diabetes Care 41, no. 1 (January 2018): 14-31.

PMID
29263194
Full Text

Sharma, A, Green, JB, Dunning, A, Lokhnygina, Y, Al-Khatib, SM, Lopes, RD, Buse, JB, Lachin, JM, Van de Werf, F, Armstrong, PW, Kaufman, KD, Standl, E, Chan, JCN, Distiller, LA, Scott, R, Peterson, ED, Holman, RR, and TECOS Study Group, . "Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial." Diabetes Care 40, no. 12 (December 2017): 1763-1770.

PMID
28986504
Full Text

Butler, J, Hamo, CE, Filippatos, G, Pocock, SJ, Bernstein, RA, Brueckmann, M, Cheung, AK, George, JT, Green, JB, Januzzi, JL, Kaul, S, Lam, CSP, Lip, GYH, Marx, N, McCullough, PA, Mehta, CR, Ponikowski, P, Rosenstock, J, Sattar, N, Salsali, A, Scirica, BM, Shah, SJ, Tsutsui, H, Verma, S, Wanner, C, Woerle, H-J, Zannad, F, Anker, SD, and EMPEROR Trials Program, . "The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors." European Journal of Heart Failure 19, no. 11 (November 2017): 1390-1400. (Review)

PMID
28836359
Full Text

Navar, AM, Gallup, DS, Lokhnygina, Y, Green, JB, McGuire, DK, Armstrong, PW, Buse, JB, Engel, SS, Lachin, JM, Standl, E, Van de Werf, F, Holman, RR, Peterson, ED, and TECOS Study Group, . "Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin." Hypertension (Dallas, Tex. : 1979) 70, no. 5 (November 2017): 907-914.

PMID
28847886
Full Text

Pages